Medirom Healthcare Technologies (MRM) Long-Term Investments (2019 - 2024)
Medirom Healthcare Technologies has reported Long-Term Investments over the past 6 years, most recently at $575015.9 for Q4 2024.
- Quarterly results put Long-Term Investments at $575015.9 for Q4 2024, up 4.24% from a year ago — trailing twelve months through Dec 2024 was $575015.9 (up 4.24% YoY), and the annual figure for FY2024 was $575015.9, up 4.24%.
- Long-Term Investments for Q4 2024 was $575015.9 at Medirom Healthcare Technologies, up from $551650.6 in the prior quarter.
- Over the last five years, Long-Term Investments for MRM hit a ceiling of $575015.9 in Q4 2024 and a floor of $4785.0 in Q4 2020.
- Median Long-Term Investments over the past 5 years was $466430.5 (2021), compared with a mean of $394634.9.
- Biggest five-year swings in Long-Term Investments: tumbled 96.3% in 2020 and later soared 9647.7% in 2021.
- Medirom Healthcare Technologies' Long-Term Investments stood at $4785.0 in 2020, then soared by 9647.7% to $466430.5 in 2021, then fell by 19.54% to $375292.4 in 2022, then soared by 46.99% to $551650.6 in 2023, then rose by 4.24% to $575015.9 in 2024.
- The last three reported values for Long-Term Investments were $575015.9 (Q4 2024), $551650.6 (Q4 2023), and $375292.4 (Q4 2022) per Business Quant data.